What is high-risk mantle cell lymphoma, and how should we treat it? Journal Article

  

Authors:	Epstein-Peterson, Z.; Kumar, A.
Article Title:	What is high-risk mantle cell lymphoma, and how should we treat it?
Keywords:	overall survival; mutation; risk assessment; immunotherapy; chromosome aberrations; karyotyping; staining and labeling; progression-free survival; antineoplastic agents -- therapeutic use; treatment outcomes; chemotherapy, cancer; lymphoma, non-hodgkin's -- therapy; lymphoma, non-hodgkin's -- risk factors; hematopoietic stem cell transplantation -- utilization; allografts -- utilization
Journal Title:	Targeted Therapies in Oncology
Volume:	13
Issue:	2
ISSN:	1539-8226
Publisher:	MJH Life Sciences
Date Published:	2024-02-01
Start Page:	72
End Page:	74
Language:	English
PROVIDER:	EBSCOhost
PROVIDER:	cinahl plus with full text
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=rzh&AN=175884355&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Accession Number: 175884355 -- Entry Date: 20240311 -- Revision Date: 20240312 -- Publication Type: Journal Article; pictorial; questions and answers; tables/charts. -- Source: CINAHL Plus with Full Text

https://synapse.mskcc.org/synapse/works/has_related_data_chk/219605